by Hyunyu Jeon, Soo-Hyun Kim, Dayeon Shin Objective Dairy products are known to improve blood lipid profiles and insulin sensitivity and to reduce risk factors for metabolic syndrome (MetS) and nonalcoholic fatty liver disease (NAFLD). However, the mechanisms through which dairy product consumption influences NAFLD via MetS components remain unclear.
This study examined the mediating effects of MetS components on the association between dairy product consumption and NAFLD. Methods This study included 12,775 Korean adults from the Korea National Health and Nutrition Examination Survey (KNHANES) 2019–2021.
Dairy product intake was assessed using a 24-hour dietary recall. NAFLD was defined using a hepatic steatosis index score >36, and MetS was classified according to the National Cholesterol Education Program Adult Treatment Panel III criteria.
Multivariable logistic regression analyses were conducted to examine the associations among dairy intake, NAFLD, and MetS components. Mediation analyses with bootstrapping (n = 1,000) were performed to investigate the mediating effects of individual MetS components on the association between dairy consumption and NAFLD.
PLOS ONE (Medicine) published a clinical update in Research Highlights on 10 Apr 2026.
The item focuses on Examining the mediating effects of metabolic syndrome components on the relationship between dairy product consumption and nonalcoholic fatty liver disease in Korean adults.
Review the original article for the full source wording and details.